Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Systemic Vasculitis

Virginia Hughes  |  Issue: March 2008  |  March 1, 2008

Takayasu’s arteritis is like the other vasculitides, though, in that it is very uncommon—Dr. Bacon said there is only one case per million population in the U.K.—and in that its extremely challenging to diagnose. The inflammation can exist for many years, producing mild or non-specific symptoms, arthralgia or mylalgias until there is a evidence of serious vascular insufficiency such as claudication, angina or a major complication, such as stroke; aortic regurgitation may also occur because of valve involvement. The vast majority of patients with Takayasu’s arteritis are treated with prednisone.

Dr. Bacon discussed various factors to look for when diagnosing Takayasu’s arteritis. “The major factor, unfortunately, is pulse loss,” he said, though the disease can be detected using other tests before it progresses that far. Angiograms, which show narrowing or occlusion of the blood vessels, are currently the standard diagnostic test. But an angiogram “doesn’t tell you anything about what’s going on in the blood vessel wall, so it can’t distinguish disease activity from scars and is therefore a poor guide to therapy,” he explained. Recent studies have shown that advanced MRI can show wall thickening both in the aorta and in all the major arterial segments. “Therefore, this is a clear advance in assessing the degree of activity of the disease,” he said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Virginia Hughes is a medical writer based in New York City.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumVasculitis Tagged with:ACR/ARHP Annual MeetingarteritisClinical researchDiagnostic CriteriaVasculitis

Related Articles

    In Memoriam: Paul Bacon, MD

    June 1, 2010

    Paul A. Bacon, MD, considered the father of BVAS

    Wegener’s Granulomatosis Treatment Today

    October 1, 2008

    WG has an evolving prognosis and treatment course

    Fellow’s Forum Case Report: Takayasu’s Arteritis

    May 1, 2014

    How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

    Research Offers Insight into Diagnosis, Treatment of Small-Vessel Vasculitis

    March 20, 2017

    WASHINGTON, D.C.—Experts speaking at the 2016 ACR/ARHP Annual Meeting session, Update on Small-Vessel Vasculitis, offered insight into the latest approaches to the diagnosis and treatment of diseases involving the inflammation of blood vessels. “Vasculitis is an immune-mediated process. White blood cells invade the vessel wall, causing inflammation throughout the vessel wall,” said Jason M. Springer,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences